Due to multiple factors including content scraping and copyright infringement, Radio Free Hub City must now lock some of our more in-depth reporting behind a paywall. Please click here to learn more.
Bausch + Lomb has initiated a voluntary recall of several intraocular lens (IOL) products within its enVista platform, following reports of toxic anterior segment syndrome (TASS) in a small percentage of patients. The recall affects the enVista Aspire™, enVista Envy™, and specific enVista® Monofocal models currently distributed in the United States. Although the condition has reportedly responded well to treatment in all known cases, the company is acting out of caution as it investigates the root cause.
Continues after this brief message…
Did you know? Paid supporters get a reduced ad experience!
Thank you for supporting Radio Free Hub City!
The recalled lenses include various toric and monofocal models identifiable by specific model prefixes: “EA” for Aspire, “EN” for Envy, and “EE” for monofocal lenses, among others. According to the company, all lots of these models are being withdrawn. TASS is an inflammatory complication that can occur within 12 to 48 hours following cataract surgery. While the incident rate of the complication is estimated at 1–2% among affected lenses, Bausch + Lomb stated that no cases have required lens removal, and patients have shown positive recovery outcomes.
The company is actively reaching out to eyecare professionals with instructions for product return and patient monitoring guidelines. Patients who have recently undergone cataract surgery using any of the impacted products are advised to immediately report any eye discomfort. Healthcare providers are urged to monitor patients for at least two days post-surgery and respond promptly to any worsening symptoms.
Article continues after these messages…
In a time where local news media coverage seems to be disappearing, your contribution is more important than ever. While our in-depth articles are for supporting members only, we won’t put our core news content behind a paywall, because we believe access to news should be democratized, instead of access for only those who can afford it.
But keeping the lights on and taking the fight to local accountability takes resources. Your monthly subscription directly funds our public records requests, website hosting, and time spent analyzing local government and events so you don’t have to.
We are the only newsroom in Washington County with facts-first focus, locally owned, independent, while keeping our core news content free. Will you help us keep it that way?
Bausch + Lomb emphasized its commitment to patient safety and its intent to restore the enVista line once the underlying issue is identified and resolved. In the interim, the company has made support resources and detailed recall documentation available to clinicians and patients. Reports of adverse events related to the affected lenses can be submitted to Bausch + Lomb directly or through the FDA’s MedWatch program.
Article by multiple RFHC contributors, based upon information from the FDA
Do you believe we got something wrong? Please read our publishing standards and corrections policy.
Video Spotlight
Did you know? Supporters get a reduced ad experience!
Sponsored Articles
Get daily and breaking news for Washington County, MD area from Radio Free Hub City. Sign up with your email today!
Paid supporters have a reduced ad experience!
Discover more from Radio Free Hub City
Subscribe to get the latest posts sent to your email.



